We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microarray Products for Far East Market

By Labmedica staff writers
Posted on 12 Mar 2006
According to a new agreement, SciGene (Sunnyvale, CA, USA) has given ScienceWerke (Singapore) exclusive rights to market and support SciGene's microarray products in Singapore and Malaysia.

SciGene produces instruments using process control, automation, and protocol optimization to reduce microarray data errors, enabling users to quickly obtain reliable results. More...
ScienceWerke focuses on novel and emerging technologies in the genomics and proteomics market segments.

Under the agreement, ScienceWerke will be supplying its customers in Singapore and Malaysia with SciGene's newest products for the microarray laboratory. These will include the Hybex microarray incubation system and the Little Dipper microarray processor. ScienceWerke envisages immediate acceptance of the BriteSpot microarray workstation by the microarray community there.

The president of SciGene, Dr. Jim Stanchfield, said that his company is fortunate to have found ScienceWerke, "A unique company that really understand the needs of the microarray laboratory, which can give high-quality technical support in a growing market.”





Related Links:
SciGene
ScienceWerke

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automated Urinalysis Solution
UN-9000
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.